Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromes.

Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromes.

Journal: Current opinion in endocrinology, diabetes, and obesity
Published: November 10, 2025

The Efficacy and Safety of Plozasiran on Lipid Profile in Dyslipidemic Disorders: A Systematic Review and Meta-Analysis.

The Efficacy and Safety of Plozasiran on Lipid Profile in Dyslipidemic Disorders: A Systematic Review and Meta-Analysis.

Journal: Cardiovascular drugs and therapy
Published: October 10, 2025

An Updated Review of Novel Triglyceride-Lowering Therapies in Adults with Familial Chylomicronemia Syndrome.

An Updated Review of Novel Triglyceride-Lowering Therapies in Adults with Familial Chylomicronemia Syndrome.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: August 20, 2025

Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease.

Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease.

Journal: Current atherosclerosis reports
Published: July 17, 2025

Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide.

Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide.

Journal: American journal of preventive cardiology
Published: July 02, 2025

ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?

ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?

Journal: Current atherosclerosis reports
Published: June 28, 2025

Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors.

Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: June 23, 2025

Discovery of long-acting APOC3 siRNA for treating patients with hypertriglyceridemia.

Discovery of long-acting APOC3 siRNA for treating patients with hypertriglyceridemia.

Journal: Nucleic acids research
Published: June 16, 2025

Course of Pregnancy in a Woman With Familial Chylomicronemia Syndrome Treated With Plozasiran, a Small Interfering RNA Against ApoC3.

Course of Pregnancy in a Woman With Familial Chylomicronemia Syndrome Treated With Plozasiran, a Small Interfering RNA Against ApoC3.

Journal: JIMD reports
Published: June 06, 2025

Population Pharmacokinetic Modeling of Subcutaneous Plozasiran in Healthy Volunteers and Patients with Familial Chylomicronemia Syndrome, Severe Hypertriglyceridemia, and Mixed Hyperlipidemia.

Population Pharmacokinetic Modeling of Subcutaneous Plozasiran in Healthy Volunteers and Patients with Familial Chylomicronemia Syndrome, Severe Hypertriglyceridemia, and Mixed Hyperlipidemia.

Journal: Journal of clinical pharmacology
Published: April 23, 2025

Glycerol Kinase Gene Variant as a Cause of Pseudohypertriglyceridemia and Apparent Poor Response to Plozasiran.

Glycerol Kinase Gene Variant as a Cause of Pseudohypertriglyceridemia and Apparent Poor Response to Plozasiran.

Journal: JCEM case reports
Published: April 18, 2025

Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.

Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.

Journal: The New England journal of medicine
Published: April 11, 2025
Showing 1-12 of 42

Last Updated: 01/07/2026